New research finds that just 90 minutes of weekly strength training could reverse biological aging by 4 years, with increased ...

MAIA Biotechnology (MAIA) announced the publication of preclinical data for its lead proprietary telomere-targeting THIO dimer in the ...

MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug ...

Biongevity Clinic, Dubai’s premier longevity clinic powered by Canada’s BioAro, is making waves in the health and wellness ...

Researchers have discovered that the earliest days of embryo development have a measurable impact on a person's future health and aging.

Telomir Pharmaceuticals (NASDAQ: TELO) announced preclinical findings showing that its telomere-elongating drug, Telomir-1, reduced tumor size by app ...

Researchers at the University of Adelaide have found that the initial stages of embryo development significantly influence an ...

MAIA Biotechnology Receives USAN Council Approval for "Ateganosine" as Nonproprietary Name for Anticancer Agent THIO ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

New research reveals that the earliest days of embryo development have a measurable impact on a person’s future health and ...

Researchers from the University of Adelaide have discovered that the earliest days of embryo development have a measurable ...